Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Meta Platforms, Inc. in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Meta securities between April 29, 2021 and October 21, 2021, both dates inclusive . Investors .
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meta Platforms, Inc. fka Facebook, Inc. between November 3, 2016 and October 4, 2021, inclusive of the important December 27, 2021 lead plaintiff deadline in the securities class action first filed by the firm. SO WHAT: If you purchased Facebook securities during the Class Period you may be entitled to compensation .
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Meta Platforms, Inc. fka Facebook, Inc. for violations of ยงยง10 and 20 of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company s securities between November 3, 2016, and October 4, 2021, .
The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recoveryEargo, Inc. This lawsuit .
Chosen companies will have access to BlackBerry IVY to deliver high-impact transportation use cases leveraging in-vehicle data BlackBerry Limited and L-SPARK Canada s largest software-as-a-service accelerator, today announced a third phase of their joint accelerator program, which aims to grow Canadian technology companies focused on connected vehicle solutions. Following the success of the first and second cohorts .